Clinical trials
Lymphoma trials in France with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2004 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| University Hospital, Caen | 2 |
| University Hospital, Toulouse | 2 |
| Association Francaise pour la Recherche Thermale | 1 |
| Centre Henri Becquerel | 1 |
| Commissie Voor Klinisch Toegepast Onderzoek | 1 |
| European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma | 1 |
| Hospices Civils de Lyon | 1 |
| Institut Paoli-Calmettes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 19 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia | 5 |
| Lymphoma, Follicular | 4 |
| Burkitt Lymphoma | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Acute | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Large-Cell, Immunoblastic | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.